1. A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax®). (October 2012) Authors: Harrison, Simon J; Bishton, Mark; Bates, Susan E; Grant, Steven; Piekarz, Richard L; Johnstone, Ricky W; Dai, Yun; Lee, Becki; Araujo, Maria E; Prince, H Miles Journal: Epigenomics Issue: Volume 4:Number 5(2012) Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant‐eligible patients with previously untreated mantle cell lymphoma. Issue 3 (24th May 2019) Authors: Ng, Zi Yun; Bishton, Mark; Ritchie, David; Campbell, Robert; Gilbertson, Michael; Hill, Kate; Ratnasingam, Sumita; Schwarer, Anthony; Manos, Kate; Shorten, Sophie; Ng, Melissa; Nelson, Niles; Xin, Liu; De Mel Widanalage, Sanjay; Sunny, Tenny; Purtill, Duncan; Poon, Michelle; Johnston, Anna; Cochr... Journal: Hematological oncology Issue: Volume 37:Issue 3(2019) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Allogeneic haematopoietic stem cell transplantation for VEXAS syndrome: UK experience. (2nd October 2022) Authors: Al‐Hakim, Adam; Poulter, James A.; Mahmoud, Dina; Rose, Ailsa M. S.; Elcombe, Suzanne; Lachmann, Helen; Cargo, Catherine; Duncan, Christopher J. A.; Bishton, Mark; Bigley, Venetia; Khan, Anjum; Savic, Sinisa Journal: British journal of haematology Issue: Volume 199:Number 5(2022) Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing. Issue 5 (20th March 2023) Authors: Arulogun, Suzanne O.; Brian, Duncan; Goradia, Harshita; Cooney, Aaron; Menne, Tobias; Koo, RayMun; O'Neill, Aideen T.; Vos, Josephine M. I.; Pratt, Guy; Turner, Deborah; Marshall, Kirsty; Manos, Kate; Anderson, Claire; Gavriatopoulou, Maria; Kyriakou, Charalampia; Kersten, Marie J.; Minnema, Moni... Journal: American journal of hematology Issue: Volume 98:Issue 5(2023) Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Extended follow‐up of CD4+ T cell recovery kinetics in a large cohort of patients with B‐cell lymphoproliferative disease treated with rituximab‐bendamustine. Issue 1 (4th September 2020) Authors: Gaiolla, Rafael; Hartley, Sarah; Beech, Amy; Knight, Helen; Smith, Dean; Bishton, Mark; Fox, Christopher P.; Martinez‐Calle, Nicolas Journal: Hematological oncology Issue: Volume 39:Issue 1(2021) Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Frontline management of nodular lymphocyte predominant Hodgkin lymphoma – a retrospective UK multicentre study. (25th July 2019) Authors: Wilson, Matthew R.; Bagguley, Timothy; Smith, Alexandra; Roman, Eve; Patmore, Russell; Hanlon, Katharine; Leach, Mike; Bishton, Mark; Burton, Cathy; McKay, Pam Journal: British journal of haematology Issue: Volume 186:Number 6(2019) Page Start: e214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients. (23rd February 2021) Authors: McCulloch, Rory; Lewis, David; Crosbie, Nicola; Eyre, Toby A.; Bolam, Simon; Arasaretnam, Anita; Creasey, Thomas; Goradia, Harshita; McMillan, Annabel; Dawi, Safia; Harrison, Samuel; Miles, Oliver; Robinson, Andrew; Dutton, David; Wilson, Matthew R.; McKay, Pam; Follows, George; Phillips, Neil; P... Journal: British journal of haematology Issue: Volume 193:Number 2(2021) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: A national registry study from England, 2013–2019. (19th September 2022) Authors: Liu, Hanhua; Stiller, Charles A.; Crooks, Colin J.; Rous, Brian; Bythell, Mary; Broggio, John; Rankin, Judith; Nanduri, Vasanta; Lanyon, Peter; Card, Tim R.; Ban, Lu; Elliss‐Brookes, Lucy; Broughan, Jennifer M.; Paley, Lizz; Wong, Kwok; Bacon, Andrew; Bishton, Mark; West, Joe Journal: British journal of haematology Issue: Volume 199:Number 5(2022) Page Start: 728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Kinetics of T‐cell subset reconstitution following treatment with bendamustine and rituximab for low‐grade lymphoproliferative disease: a population‐based analysis. (13th December 2018) Authors: Martínez‐Calle, Nicolás; Hartley, Sarah; Ahearne, Matthew; Kasenda, Benjamin; Beech, Amy; Knight, Helen; Balotis, Constantine; Kennedy, Ben; Wagner, Simon; Dyer, Martin J. S.; Smith, Dean; McMillan, Andrew K.; Miall, Fiona; Bishton, Mark; Fox, Christopher P. Journal: British journal of haematology Issue: Volume 184:Number 6(2019) Page Start: 957 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐CHOP. (24th April 2019) Authors: Eyre, Toby A.; Martinez‐Calle, Nicolas; Hildyard, Catherine; Eyre, David W.; Plaschkes, Hannah; Griffith, John; Wolf, Julia; Fields, Paul A.; Gunawan, Arief; Oliver, Rebecca; Booth, Stephen; McMillan, Andrew; Fox, Christopher P.; Bishton, Mark; Collins, Graham P.; Hatton, Chris S. R. Journal: British journal of haematology Issue: Volume 186:Number 4(2019) Page Start: e94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗